Posted by Michael Wonder on 20 Jan 2022
TGA provisionally approves Novavax (Biocelect) COVID-19 vaccine Nuvaxovid
20 January 2022 - The Therapeutic Goods Administration has granted provisional approval to Biocelect (on behalf of Novavax) for its COVID-19 vaccine, Nuvaxovid.
This is the first protein COVID-19 vaccine to receive regulatory approval in Australia.
